Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Collaboration crawled date : 2021 - 04 - 13 save search
Waters and Genovis Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization
Published: 2021-04-13 (Crawled : 13:00) - biospace.com/
WAT | $299.23 1.06% 0.0% 290K
|
Health Technology
|
| O: 0.05%
H: 0.35%
C: 0.23%
biopharma collaboration
BridgeBio Pharma, Inc. and GlycoNet Initiate Collaboration to Discover Potential Treatments for Genetic Diseases through Glycomics Research
Published: 2021-04-13 (Crawled : 12:00) - globenewswire.com
BBIO | $25.07 1.33% 1.39% 1.9M
|
Health Technology
|
| O: 0.43%
H: 2.42%
C: 0.76%
disease treatment genetic potential collaboration research
BridgeBio Pharma, Inc. and Oregon Health & Science University Establish Collaboration to Translate Pioneering Research into Therapies for Genetically Driven Diseases
Published: 2021-04-13 (Crawled : 12:00) - globenewswire.com
BBIO | $25.07 1.33% 1.39% 1.9M
|
Health Technology
|
| O: 0.43%
H: 2.42%
C: 0.76%
disease genetic collaboration research therapy
BridgeBio Pharma, Inc. and Roswell Park Establish Collaboration to Translate Pioneering Research into Therapies for Genetically Driven Cancers
Published: 2021-04-13 (Crawled : 12:00) - globenewswire.com
BBIO | $25.07 1.33% 1.39% 1.9M
|
Health Technology
|
| O: 0.43%
H: 2.42%
C: 0.76%
genetic collaboration cancer research therapy pharma
BridgeBio Pharma, Inc. and The Lundquist Institute Collaborate to Advance Treatments for Genetically Driven Conditions and Cancers
Published: 2021-04-13 (Crawled : 12:00) - biospace.com/
BBIO | $25.07 1.33% 1.39% 1.9M
|
Health Technology
|
| O: 0.43%
H: 2.42%
C: 0.76%
treatment genetic cancer collaboration pharma
BridgeBio Pharma and the University of California, San Diego Announce Collaboration to Advance Treatments for Genetically Driven Conditions
Published: 2021-04-13 (Crawled : 12:00) - biospace.com/
BBIO | $25.07 1.33% 1.39% 1.9M
|
Health Technology
|
| O: 0.43%
H: 2.42%
C: 0.76%
treatment genetic collaboration announces collaboration pharma
BridgeBio Pharma, Inc. and UC Davis Establish Collaboration to Transform Research into Potential Therapies for Genetically Driven Diseases
Published: 2021-04-13 (Crawled : 12:00) - biospace.com/
BBIO | $25.07 1.33% 1.39% 1.9M
|
Health Technology
|
| O: 0.43%
H: 2.42%
C: 0.76%
disease genetic potential collaboration research therapy
Evotec Launches 'BeLAB2122', Translating Academic Innovation from Leading German Life Science Region in Collaboration with Bristol Myers Squibb
Published: 2021-04-13 (Crawled : 08:00) - biospace.com/
BMY | $49.14 0.43% 0.12% 6.4M
|
Health Technology
|
| O: 0.35%
H: 1.32%
C: 1.07%
SNY | News | $47.15 1.84% 1.75% 2M
|
Health Technology
|
| O: -0.66%
H: 0.86%
C: 0.48%
collaboration life science germany
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
MTTR | News M | $4.8 175.86% 63.6% 71M
|
AGBA | $2.5 100.0% 56.6% 200M
|
Finance
MLEC | $2.47 76.43% 42.62% 78M
|
n/a
NUWE | $0.334 29.96% 40.99% 2.5M
|
Manufacturing
EDBL | News | $6.26 66.49% 40.13% 16M
|
ATGL | $2.86 46.25% 32.8% 180K
|
ONFO | $0.6088 38.68% 27.74% 7.3M
|
n/a
VIVK | $1.43 33.65% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.7M
|
SDIG A | $3.64 35.32% 26.0% 990K
|
Your saved searches
Save your searches and get alerts when important news are released.